Andrew Regan Insider Profile

4 Followers
Andrew Regan, Director, Ten Percent Owner at Conduit Pharmaceuticals, holds 244.28K shares in Conduit Pharmaceuticals (Ticker: CDT).
tipranks
Andrew Regan

Andrew Regan
Conduit Pharmaceuticals (CDT)
Director, Ten Percent Owner

Not Ranked
Andrew Regan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$21K
100.00%
A breakdown of Andrew Regan's holdings

Insider Roles

Conduit Pharmaceuticals
(CDT)
Director, Ten Percent Owner
Roles that Andrew Regan holds in companies

Most Profitable Insider Trade

Stock:
Conduit Pharmaceuticals
(CDT)
Rating:Informative Sell
Date:Sep 19, 2024 - Today
Return:+33.80%
The most profitable trade made by Andrew Regan

Andrew Regan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Conduit Pharmaceuticals
Sep 19, 2024
Director, Ten Percent Owner
Uninformative Buy
$21.50K
Success Rate for
CDT
1 out of 1 profitable transactions on
CDT
100%
Average Return for
CDT
Average return per transaction on
CDT
+33.80%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Sep 19, 2024
Uninformative Buy
$0.00
-
$0.00
Sep 19, 2024
Uninformative Sell
$0.00
-
$0.00
Sep 19, 2024
Informative Sell
$4.49M
-
$0.29
+33.80%
List of latest transactions for each holding click on a transaction to see Andrew Regan's performance on stock

Andrew Regan insider profile FAQ

What is the percentage of profitable transactions made by Andrew Regan?
The percentage of profitable transactions made by Andrew Regan is ―.
    What is the average return per transaction made by Andrew Regan?
    The average return per transaction made by Andrew Regan is ―.
      What stocks does Andrew Regan hold?
      Andrew Regan holds: CDT stocks.
        What was Andrew Regan’s latest transaction?
        Andrew Regan latest transaction was an Uninformative Buy of ―.
          What was Andrew Regan's most profitable transaction?
          Andrew Regan’s most profitable transaction was an Informative Sell of CDT stock on September 19, 2024. The return on the trade was 33.80%.
            What is Andrew Regan's role in Conduit Pharmaceuticals?
            Andrew Regan's role in Conduit Pharmaceuticals is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.